Publication | Closed Access

567 Serum alpha-fetoprotein (AFP) levels in patients with advanced hepatitis C-associated liver disease without hepatocellular carcinoma: Results from the HALT-C trial

Hepatic DisordersHepatologyHepatitis CViral HepatitisLiver PhysiologyHalt-c TrialImmunologyHepatitisPathologyLiver DiseaseLiver CancerSerum Alpha-fetoproteinMedicineHepatocellular CarcinomaCirrhosis